Search by Drug Name or NDC
NDC 00024-5922-02 KEVZARA 200 mg/1.14mL Details
KEVZARA 200 mg/1.14mL
KEVZARA is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by sanofi-aventis U.S. LLC. The primary component is SARILUMAB.
MedlinePlus Drug Summary
Sarilumab injection is used alone or with other medications to treat rheumatoid arthritis (RA: condition in which the body attacks its own joints causing pain, swelling, and loss of function). Sarilumab is usually used by people who were not helped by certain other drugs for RA or who could not take these medications. Sarilumab injection is in a class of medications called interleukin-6 (IL-6) receptor inhibitors. It works by blocking the activity of interleukin-6, a substance in the body that causes inflammation.
Related Packages: 00024-5922-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sarilumab Injection
Product Information
NDC | 00024-5922 |
---|---|
Product ID | 0024-5922_ca91dfdd-7d4f-4074-bbfd-d8fc21deac46 |
Associated GPIs | 6650006000D530 |
GCN Sequence Number | 078047 |
GCN Sequence Number Description | sarilumab PEN INJCTR 200MG/1.14 SUBCUT |
HIC3 | Z2V |
HIC3 Description | INTERLEUKIN-6 (IL-6) RECEPTOR INHIBITORS |
GCN | 44277 |
HICL Sequence Number | 044183 |
HICL Sequence Number Description | SARILUMAB |
Brand/Generic | Brand |
Proprietary Name | KEVZARA |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | sarilumab |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 200 |
Active Ingredient Units | mg/1.14mL |
Substance Name | SARILUMAB |
Labeler Name | sanofi-aventis U.S. LLC |
Pharmaceutical Class | Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA761037 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00024-5922-02 (00024592202)
NDC Package Code | 0024-5922-02 |
---|---|
Billing NDC | 00024592202 |
Package | 2 SYRINGE in 1 PACKAGE (0024-5922-02) / 1.14 mL in 1 SYRINGE |
Marketing Start Date | 2018-04-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |